Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants

NCT00143312 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Prophylaxis Of Invasive Fungal Infections

Interventions

DRUG: voriconazole

Sponsor

Pfizer

Collaborators

[object Object]